Rocket Lab USA, Inc. — Q2 2022 Form 10-Q
Reporting period: Three and six months ended June 30, 2022. Amounts below are in U.S. dollars; financial statement amounts are in millions unless noted. The filing describes Rocket Lab as an end-to-end space company, with Launch Services and Space Systems reporting segments.
Financial performance and position
| Metric | Q2 2022 | Q2 2021 | H1 2022 | H1 2021 |
|---|---|---|---|---|
| Revenue | $55.5 | $11.3 | $96.2 | $29.5 |
| Gross profit | $5.0 | $2.5 | $8.7 | $3.9 |
| Gross margin | 8.9% | 21.8% | 9.0% | 13.1% |
| Operating loss | $(33.2) | $(13.1) | $(66.0) | $(25.4) |
| Net loss | $(37.4) | $(16.7) | $(64.1) | $(32.5) |
| Operating cash used | — | $(64.6) | $(36.6) | |
| Investing cash used | — | $(84.1) | $(5.7) |
- Q2 revenue rose 392% year over year; H1 revenue rose 226%. Growth included substantial contributions from recent acquisitions and organic Space Systems growth. In Q2, Launch Services generated $19.1 million and Space Systems $36.4 million; Space Systems contributed $7.3 million of segment gross profit, while Launch Services had a $2.3 million gross loss.
- H1 cost of revenue increased to 91% of revenue from 87% in the prior-year period. Management cited higher launch cadence, acquired businesses, and increased stock-based compensation. Revenue value per launch was $6.3 million in both Q2 and H1 2022, below the respective prior-year figures of $7.2 million and $7.6 million; reported cost per launch was $7.1 million in Q2 and $7.2 million in H1.
- Q2 net loss included a $3.9 million foreign-exchange loss and $2.4 million net interest expense. H1 included a $13.5 million noncash gain from changes in warrant fair value, which partly offset operating and other losses; warrants were no longer outstanding at June 30.
- At June 30, cash and cash equivalents were $542.5 million, restricted cash was $4.1 million, total assets were $1,004.8 million, and stockholders’ equity was $713.5 million. H1 cash and restricted cash declined by $145.4 million, including $65.1 million of net acquisition payments and $19.1 million of capital expenditures.
- Long-term borrowings totaled $101.5 million, including $2.9 million current. The secured Hercules loan matures June 1, 2024, bears cash interest at the greater of 8.15% or 8.15% plus the prime rate minus 3.25%, and accrues 1.25% payment-in-kind interest. It is secured by substantially all company assets; no further availability remained. The company reported compliance with debt covenants.
Changes, outlook, and risks
- Revenue and operating scale expanded, but gross margin fell and operating and net losses increased. The comparison is affected by acquisitions completed in late 2021 and early 2022, including SolAero, whose reported H1 2022 revenue was $40.1 million.
- Backlog was $531.4 million at June 30: $135.0 million Launch Services and $396.4 million Space Systems. Approximately 42% was expected to be recognized within 12 months. The filing notes that launch and spacecraft contracts may include customer termination rights.
- Management anticipated building approximately 12–15 Electron vehicles in 2022. Rocket Lab reported four launches through June 30 and six through August 11, 2022. It was developing Neutron and constructing a production complex in Virginia; the filing gives no specific Neutron launch date or financial forecast.
- Management said existing cash and expected customer payments should fund working capital and capital expenditure needs for at least 12 months, while noting significant planned investment and that additional financing may be needed. Future cash needs depend on launch cadence, product development, acquisitions, and other factors.
- SolAero acquisition consideration was $76.2 million; the company also paid $65.1 million net of acquired cash and restricted cash for acquisitions during H1. Acquisition integration, execution, supply-chain constraints, launch failures or delays, customer funding and contract cancellations, foreign-exchange movements, inflation, interest rates, and government spending were among the disclosed risks.
- Disclosure controls and procedures were deemed ineffective as of June 30, 2022 because previously identified material weaknesses in financial reporting controls remained. Management described remediation work, including added personnel and review and IT controls; effectiveness still required sustained validation and testing.
- A provision of $5.5 million remained for losses on a legacy fixed-price launch agreement. Management said pending ordinary-course legal matters were not expected to have a material adverse effect.
- After quarter-end, the CAPSTONE payload was deployed toward the Moon in July following launch and transportation by Electron and Lunar Photon. The filing also states that the company would lose emerging-growth-company status on December 31, 2022.
Important facts for investors to verify
- How much revenue growth and backlog conversion are organic and repeatable versus attributable to acquisitions, and whether backlog remains firm given customer termination rights.
- Whether launch and Space Systems margins improve as production scales, given Q2 and H1 gross-margin declines and launch costs exceeding revenue value per launch.
- Cash burn, acquisition and capital-investment requirements, and the assumptions underlying management’s stated minimum 12-month liquidity outlook.
- Neutron development, construction costs, and schedule; Electron build-rate plans and realized launch cadence.
- Progress remediating material weaknesses and the timing of demonstrated effective disclosure controls.
- Debt service and refinancing exposure under the secured loan’s rate terms, maturity, collateral, and end-of-term charge.